RRBI
Red River Bancshares Inc
NASDAQ · Banking
$91.04
+0.00 (+0.00%)
RRBI News5 articles
AbbVie Gains on Moody's Credit Upgrade, Focus Shifts to Immunology Portfolio
AbbVie shares rose 2% to $223.43 after Moody's upgraded its credit rating to A2 with a stable outlook. Investors now watch demand and pricing for Skyrizi and Rinvoq amid Humira competition.
Standard Chartered Shares Gain Ahead of Key Results and Dividend Decision
Standard Chartered shares outperformed the FTSE 100, rising 1.87% to £18.82. Investors await the bank's full-year results and final dividend decision on February 24.
NXP Secures $3B Credit Facility as Chip Sector Rallies on AI Spending
NXP Semiconductors amended a $3 billion revolving credit line with Barclays, maturing in 2031, while the broader chip sector surged on AI investment signals from major tech firms.
AbbVie Shares Gain 2% to Close Near $223 Amid Earnings Volatility, Credit Upgrade
AbbVie stock rose 2% Friday, ending a turbulent week marked by earnings scrutiny and a Moody's credit rating upgrade. Investors remain focused on Skyrizi and Rinvoq growth amid competitive pressures.
SK Hynix Shares Dip Amid Tech Sell-Off Despite S&P Credit Upgrade
SK Hynix shares declined 0.36% to 839,000 won on Friday, extending a weekly loss of 8% as Asian tech stocks retreated, even after S&P upgraded its credit rating to BBB+ with a positive outlook.